血管生成素樣蛋白4(ANGPTL4)多克隆抗體(異硫氰酸熒光素標(biāo)記)
FITC-Linked Polyclonal Antibody to Angiopoietin Like Protein 4 (ANGPTL4)
ARP4; FIAF; HFARP; NL2; PGAR; Pp1158; Fasting-Induced Adipose Factor; Hepatic Angiopoietin-Related Protein; Hepatic Fibrinogen/Angiopoietin-Related Protein
- 編號(hào)LAB019Ra81
- 物種Rattus norvegicus (Rat，大鼠)相同的名稱，不同的物種。
- 來源抗體標(biāo)記
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物熒光素
- 原抗體-
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IF.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價(jià)格¥ 911¥ 2125¥ 3036¥ 7590¥ 30360
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)ANGPTL4的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別ANGPTL4。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB019Ra01 | 血管生成素樣蛋白4(ANGPTL4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB019Ra02 | 血管生成素樣蛋白4(ANGPTL4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB019Ra01 | 血管生成素樣蛋白4(ANGPTL4)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB019Ra02 | 血管生成素樣蛋白4(ANGPTL4)多克隆抗體 | IHC |
| LAB019Ra71 | 血管生成素樣蛋白4(ANGPTL4)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAB019Ra81 | 血管生成素樣蛋白4(ANGPTL4)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| MAB019Ra22 | 血管生成素樣蛋白4(ANGPTL4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB019Ra23 | 血管生成素樣蛋白4(ANGPTL4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB019Ra24 | 血管生成素樣蛋白4(ANGPTL4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB019Ra21 | 血管生成素樣蛋白4(ANGPTL4)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB019Ra | 血管生成素樣蛋白4(ANGPTL4)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB019Ra | 血管生成素樣蛋白4(ANGPTL4)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| The Journal of Biological Chemistry | Angiopoietin-like 4 (Angptl4) Protein Is a Physiological Mediator of Intracellular Lipolysis in Murine Adipocytes[PubMed: PMC3318686] |
| J Clin Endocrinol Metab. | Decreased Concentrations of the Lipoprotein Lipase Inhibitor Angiopoietin-Like Protein 4 and Increased Serum Triacylglycerol Are Associated With Increased Neonatal Fat Mass in Pregnant Women With Gestational Diabetes Mellitus [Pubmed: 23744407] |
| PloS one | Lack of Relationship between Cord Serum Angiopoietin-Like Protein 4 (ANGPTL4) and Lipolytic Activity in Human Neonates Born by Spontaneous Delivery[Pubmed: 24324678] |
| Journal of Hematology & Oncology | Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy[PubMed: 26054961] |
| Gynecol Endocrinol | Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome[PubMed: 26291814] |
| Molecular Nutrition & Food research | Interaction of Gut Microbiota and High‐sodium, Low‐potassium Diet in Altering Plasma Triglyceride Profiles Revealed by Lipidomics Analysis[Pubmed: 31675161] |
| ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE | Analysis of novel serum markers of fibrosis and angiogenesis in patients with alcoholic liver cirrhosis[] |
| Food Chem Toxicol | Di (2-ethylhexyl) phthalate exposure exacerbates metabolic disorders in diet-induced obese mice[34303773] |